GENPREX INC (GNPX:NASDAQ)
$2.24 0.2 (9.8039%)
Analysed GENPREX INC (GNPX:NASDAQ) News Sources
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
26-05-2026
yahoo.com
Genprex to Participate at BIO International Convention 2026
17-06-2026
yahoo.com
Genprex’s Reqorsa combo secures Canadian patent for lung cancer
23-06-2026
pharmaceutical-technology.com
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
03-08-2026
yahoo.com
Genprex Shares Rise After Collaboration With Roche Diagnostics
03-08-2026
advfn.com
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
18-08-2026
yahoo.com
Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
01-09-2026
yahoo.com
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08-09-2026
yahoo.com
Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
21-10-2026
yahoo.com
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
28-10-2026
yahoo.com
What is the current price of GENPREX INC (GNPX:NASDAQ)?
The current price of GENPREX INC (GNPX:NASDAQ) is $2.24.
GENPREX INC (GNPX:NASDAQ) absolute price change since previous trading day?
The absolute price change of GENPREX INC (GNPX:NASDAQ) since the previous trading day is $0.2.
GENPREX INC (GNPX:NASDAQ) percentage price change since previous trading day?
The percentage price change of GENPREX INC (GNPX:NASDAQ) since the previous trading day is 9.8039%.
What is the most recent average sentiment score for GENPREX INC (GNPX:NASDAQ)?
The most recent average sentiment score for GENPREX INC (GNPX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for GENPREX INC (GNPX:NASDAQ)?
The most recent sentiment for GENPREX INC (GNPX:NASDAQ) is .
SEC-8K** Filing Available For GENPREX INC (GNPX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.